Page 201 - GHES-2-1

Global Health Econ Sustain Assessing budget impact estimates based on official data

Brazilian Health Regulatory Agency (ANVISA). (2020). bulario/q/?nomeproduto=keytruda [Last accessed on
Conceitosand Definições.Available from: https://www.gov. 2023 Sep 02].
br/anvisa/pt-br/acessoainformacao/perguntasfrequentes/ Reck, M., Rodríguez-Abreu, D., Robinson, A.G., Hui, R., Csőszi, T.,
medicamentos/conceitos-e-definicoes/conceitos-e- Fülöp, A., et al. (2016). Pembrolizumab versus chemotherapy
definicoes [Last accessed on 2023 Sep 02]. for PD-L1 positive non-small-cell lung cancer.The New
Executive Secretariat of the Drug Market Regulation Chamber England Journal of Medicine, 375(19):1823-1833.
(SCMED). (2023). Anuário Estatístico do Mercado https://doi.org/10.1056/NEJMoa1606774
Farmacêutico 2022. Available from: https://www. Sullivan, S.D., Mauskopf, J.A., Augustovski, F., Jaime Caro, J.,
gov.br/anvisa/ptbr/centraisdeconteudo/publicacoes/ Lee, K.M., Minchin, M., et al. (2014). Budget impact
medicamentos/cmed/anuario-estatistico-2022-tabelas.xlsx/ analysis-principles of good practice: Report of the ISPOR
view [Last accessed on 2023 Sep 02]. 2012 budget impact analysis good practice II task force.
Keytruda. Package Insert. Merck Sharp DohmeFarmacêutica Value in Health, 2014;17(1):5-14.
LTDA. Available from: https://consultas.anvisa.gov.br/#/ https://doi.org/10.1016/j.jval.2013.08.2291

Volume 2 Issue 1 (2024) 3 https://doi.org/10.36922/ghes.1889